Nilanjan Chatterjee

Last updated

Nilanjan Chatterjee
Nilanjan Chatterjee.png
Bornc. 1972 (age 5051)
Alma mater University of Washington (Ph.D., 1999)
Indian Statistical Institute (M.S., 1995)
Ballygunge Government High School
Awards Mortimer Spiegelman Award (2010)
Snedecor Award (2011)
COPSS Presidents' Award (2011)
Bloomberg Distinguished Professorships (2015)
Scientific career
Fields Epidemiology
Statistics
Biostatistics
Oncology
Institutions Johns Hopkins University (current)
National Institutes of Health (1999-2015)
Thesis Semiparametric inference based on estimating equations in regressions models for two phase outcome dependent sampling
Academic advisors Norman Breslow
Jon A. Wellner

Nilanjan Chatterjee is a Bloomberg Distinguished Professor [1] of Biostatistics and Genetic Epidemiology at Johns Hopkins University, with appointments in the Department of Biostatistics in the Bloomberg School of Public Health and in the Department of Oncology in the Sidney Kimmel Comprehensive Cancer Center in the Johns Hopkins School of Medicine. [1] [2] He was formerly the chief of the Biostatistics Branch of the National Cancer Institute's Division of Cancer Epidemiology and Genetics.

Contents

Biography

Chatterjee was born in Kolkata, India, to parents Aditya Nath and Pranati Chatterjee. He attended Ballygunge Government High School and Saint Xavier's College. He received his bachelor's degree in statistics from the Indian Statistical Institute in 1993, and his master's in 1995. [3] Chatterjee earned his PhD in Statistics from the University of Washington, Seattle in 1999. [4] His PhD thesis, titled "Semiparametric Inference Based on Estimating Equations in Regression Models for Two-Phase Outcome-Dependent Sampling," was advised by Norman Breslow and Jon A. Wellner. [5]

Chatterjee joined the National Cancer Institute (NCI) as a postdoctoral fellow in the biostatistics branch of the Division of Cancer Epidemiology and Genetics (DCEG) in 1999, and became a tenure-track investigator in 2001 and a senior investigator in 2004. He served as chief of the biostatistics branch from 2008 until 2015. [3] He remains a Special Volunteer at the NCI. [6]

Research

Chatterjee is known for his work in quantitative genetics, cancer research, big data, statistical methodology, genomics, gene-environment interaction, genetic association and genome-wide association studies.

Chatterjee developed a model for predicting breast cancer risk that combines individual-level data on risk factors such as smoking and age with genetic variations associated with higher risk of breast cancer. [7] He led a large collaboration of experts from the Johns Hopkins School of Medicine, the Bloomberg School of Public Health, and the Whiting School of Engineering that used big data and machine learning to develop tools for autism risk prediction and intervention. [8] [9]

Chatterjee has participated in the Johns Hopkins Individualized Health Initiative (Hopkins inHealth), which aims to improve individual and population health outcomes through innovative collaborations among experts in biomedical and data science. [2] [10] Chatterjee's contributions to the initiative involved research on using genetic markers for risk prediction models as well as their applications to personalized medicine and public health interventions. [2]

Through his quantitative studies of gene-environment and gene-gene interactions, Chatterjee has also made fundamental contributions to theoretical and methodological approaches in epidemiology and biostatistics. [2] [3] Using statistics from genome-wide association studies to appraise the number of DNA variations that contribute to different physical traits and diseases, Chatterjee and colleagues developed a method for estimating the number of individual samples needed in order to identify genetic bases of traits, such as height or body mass index (BMI), or diseases, such as diabetes or bipolar disorder. [11] This method can be used for designing genetic studies and understanding genetic risk prediction. [12]

Awards

Publications

Chatterjee has more than 40,000 citations in Google Scholar and an h-index of 98. [15]

Highly Cited Articles (more than 1000 citations)

Related Research Articles

<span class="mw-page-title-main">Roxana Moslehi</span> Genetic epidemiologist

Roxana Moslehi is an Iranian-born genetic epidemiologist.

Genetic epidemiology is the study of the role of genetic factors in determining health and disease in families and in populations, and the interplay of such genetic factors with environmental factors. Genetic epidemiology seeks to derive a statistical and quantitative analysis of how genetics work in large groups.

Sir Bruce Anthony John Ponder FMedSci FAACR FRS FRCP is an English geneticist and cancer researcher. He is Emeritus Professor of Oncology at the University of Cambridge and former director of the Cancer Research UK Cambridge Institute and of the Cancer Research UK Cambridge Cancer Centre.

<span class="mw-page-title-main">Stephen Chanock</span> American physician and geneticist

Stephen Jacob Chanock is an American physician and geneticist. He currently serves as Director of the Division of Cancer Epidemiology and Genetics at the U.S. National Cancer Institute (NCI).

<span class="mw-page-title-main">Polygenic score</span> Numerical score aimed at predicting a trait based on variation in multiple genetic loci

In genetics, a polygenic score (PGS) is a number that summarizes the estimated effect of many genetic variants on an individual's phenotype. The PGS is also called the polygenic index (PGI) or genome-wide score; in the context of disease risk, it is called a polygenic risk score or genetic risk score. The score reflects an individual's estimated genetic predisposition for a given trait and can be used as a predictor for that trait. It gives an estimate of how likely an individual is to have a given trait based only on genetics, without taking environmental factors into account; and it is typically calculated as a weighted sum of trait-associated alleles.

Douglas F. Easton FMedSci is a British epidemiologist who conducts research on the genetics of human cancers. He is Professor of Genetic Epidemiology and Centre for Cancer Genetic Epidemiology at the University of Cambridge. He founded Cambridge's Cancer Research UK Genetic Epidemiology Unit in 1995, and was a Principal Research Fellow there from 2001 to 2011. He is a Professorial Fellow of Homerton College, Cambridge.

<span class="mw-page-title-main">Bhramar Mukherjee</span> Indian-American biostatistician, data scientist

Bhramar Mukherjee is an Indian-American biostatistician, data scientist, professor and researcher. She is the John D. Kalbfleisch Distinguished University Professor of Biostatistics, Siobán D. Harlow Collegiate Professor of Public Health and the Chair of Department of Biostatistics, a professor of epidemiology and global public health at the University of Michigan. She serves as the associate director for Quantitative Data Sciences at University of Michigan Rogel Cancer Center. Mukherjee holds a Senior Honorary Visiting Fellow position at the Biostatistics Unit of the Medical Research Council, working on the theme of population health at the University of Cambridge, UK. She has served as the past Chair for Committee of Presidents of Statistical Societies (COPSS) for a three-year term 2019-2021.

<span class="mw-page-title-main">Montserrat García-Closas</span> Spanish academic and researcher

Montserrat García-Closas, M.D., M.P.H., Dr.P.H., is a Spanish researcher and academic who is best known for her works on identifying cancer biomarkers and genetic susceptibility to cancer. Dr. García-Closas serves as the deputy director of the Division of Cancer Epidemiology & Genetics (DCEG) of the National Cancer Institute, as well as the Acting Chief of the Integrative Tumor Epidemiology Branch of the DCEG.

<span class="mw-page-title-main">Xiaohong Rose Yang</span> Biomedical scientist

Xiaohong Rose Yang is an American biomedical scientist researching the genetics of dysplastic nevus syndrome and chordoma, and etiologic heterogeneity of breast cancer. She is a senior investigator at the National Cancer Institute. Yang leads breast cancer studies in mainland China, Hong Kong, and Malaysia.

<span class="mw-page-title-main">Stephanie J. London</span> American physician

Stephanie J. London is an American epidemiologist and physician-scientist specializing in environmental health, respiratory diseases, and genetic susceptibility. She is the deputy chief of the epidemiology branch at the National Institute of Environmental Health Sciences.

Transcriptome-wide association study (TWAS) is a genetic methodology that can be used to compare the genetic components of gene expression and the genetic components of a trait to determine if an association is present between the two components. TWAS are useful for the identification and prioritization of candidate causal genes in candidate gene analysis following genome-wide association studies. TWAS looks at the RNA products of a specific tissue and gives researchers the abilities to look at the genes being expressed as well as gene expression levels, which varies by tissue type. TWAS are valuable and flexible bioinformatics tools that looks at the associations between the expressions of genes and complex traits and diseases. By looking at the association between gene expression and the trait expressed, genetic regulatory mechanisms can be investigated for the role that they play in the development of specific traits and diseases.

<span class="mw-page-title-main">Katrina A. B. Goddard</span> American genetic epidemiologist and biostatistician

Katrina A. Blouke Goddard is an American genetic epidemiologist and biostatistician specializing in public health genomics and the translation of genomic applications into clinical practice. Goddard is the director of the division of cancer control and population sciences (DCCPS) at the National Cancer Institute (NCI). She was previously the distinguished investigator and director of translational and applied genomics at the Kaiser Permanente Center for Health Research and a faculty member at Case Western Reserve University.

<span class="mw-page-title-main">Rachael Stolzenberg-Solomon</span> American epidemiologist and dietitian

Rachael Zoe Stolzenberg-Solomon is an American epidemiologist and dietitian. She is a senior investigator and head of the metabolic epidemiology branch at the National Cancer Institute.

<span class="mw-page-title-main">Patricia Hartge</span>

Patricia A. Hartge is an American cancer epidemiologist who conducted genome-wide association studies on ovarian cancer, non-Hodgkin lymphoma, melanoma, and other malignancies. From 1996 to 2013, Hartge was deputy director of the epidemiology and biostatistics program in the division of cancer epidemiology and genetics at the National Cancer Institute.

<span class="mw-page-title-main">Hannah P. Yang</span> American cancer epidemiologist

Hannah P. Yang is an American cancer epidemiologist who is a staff scientist and associate director of scientific operations in the National Cancer Institute's division of cancer epidemiology and genetics.

<span class="mw-page-title-main">Maria Teresa Landi</span> Italian epidemiologist and oncologist

Maria Teresa Landi is an Italian epidemiologist and oncologist who researches genetic and environmental determinants of lung cancer and melanoma. At the National Cancer Institute, she is a senior investigator in the integrative tumor epidemiology branch and a senior advisor for genomic epidemiology. Landi is an associate professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health.

<span class="mw-page-title-main">Ruth Pfeiffer</span> Biostatistician

Ruth Maria Pfeiffer is a biostatistician who researches risk prediction, molecular and genetic epidemiology, and electronic medical records. She is a senior investigator in the biostatistics branch at the National Cancer Institute. Pfeiffer is an elected member of the International Statistical Institute and the American Statistical Association.

<span class="mw-page-title-main">Aimée R. Kreimer</span> American cancer epidemiologist

Aimée Rebecca Kreimer is an American cancer epidemiologist who researches the etiology and prevention of human papillomavirus infection (HPV) and cancer prevention. She is a senior investigator in the infections and immunoepidemiology branch at the National Cancer Institute.

Ludmila Prokunina-Olsson is a molecular medical geneticist who conducts genetic and functional analyses downstream of genome-wide association studies (GWAS) for various human traits, including cancer, immune and infectious diseases. She is chief of the Laboratory of Translational Genomics (LTG) at the National Cancer Institute.

Sonja Ingrid Berndt is an American pharmacologist and cancer epidemiologist who researches non-Hodgkin lymphoma, prostate cancer, and anthropometric traits that are cancer risk factors. She is a senior investigator in the occupational and environmental epidemiology branch at the National Cancer Institute.

References

  1. 1 2 "Bloomberg Distinguished Professorships".
  2. 1 2 3 4 Messersmith, Julie "Nilanjan Chatterjee named Bloomberg Distinguished Professor", JHU Hub, Baltimore, 11 November 2015. Retrieved on 11 November 2015.
  3. 1 2 3 4 "Nilanjan Chatterjee Wins COPSS Awards". Amstat News. October 2011. Retrieved 15 July 2020.
  4. "Nilanjan Chatterjee, Ph.D." National Cancer Institute. January 1980.
  5. Nilanjan Chatterjee at the Mathematics Genealogy Project
  6. "Nilanjan Chatterjee, Ph.D. - Special Volunteer, biographical sketch and research interests - National Cancer Institute". dceg.cancer.gov. 1 January 1980. Retrieved 15 July 2020.
  7. "Healthy lifestyle choices can help women overcome genetic breast cancer risk". The Hub. 26 May 2016. Retrieved 15 July 2020.
  8. "30 interdisciplinary research teams receive Johns Hopkins Discovery Awards". The Hub. 11 June 2018. Retrieved 15 July 2020.
  9. "Johns Hopkins Discovery Awards: 2018 Awardees". Johns Hopkins Office of Research. 11 June 2018.
  10. "Signature Initiatives". Johns Hopkins Office of Research. 30 March 2016.
  11. Zhang, Yan; Qi, Guanghao; Park, Ju-Hyun; Chatterjee, Nilanjan (2018). "Estimation of complex effect-size distributions using summary-level statistics from genome-wide association studies across 32 complex traits" (PDF). Nature Genetics. 50 (9): 1318–1326. doi:10.1038/s41588-018-0193-x. ISSN   1546-1718. PMID   30104760. S2CID   51979576.
  12. Scullin, Robin (13 August 2018). "Understanding genetic architecture of different traits and diseases could lead to better-designed studies, researchers say". The Hub. Retrieved 15 July 2020.
  13. "Nilanjan Chatterjee was elected Fellow of the American Statistical Society". www.stat.washington.edu. Retrieved 15 July 2020.
  14. "Nilanjan Chatterjee". Johns Hopkins Bloomberg School of Public Health. Retrieved 15 July 2020.
  15. "Nilanjan Chatterjee, Bloomberg Distinguished Professor". scholar.google.co.uk. Retrieved 11 May 2021.